Integra LifeSciences Stock Hits New 52-Week Low (IART)

NEW YORK ( TheStreet) -- Integra LifeSciences Holdings (Nasdaq: IART) hit a new 52-week low Friday as it is currently trading at $27.81, below its previous 52-week low of $28.07 with 151,244 shares traded as of 9:35 a.m. ET. Average volume has been 274,300 shares over the past 30 days.

Integra LifeSciences has a market cap of $824.8 million and is part of the health care sector and health services industry. Shares are down 0.3% year to date as of the close of trading on Thursday.

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company has a P/E ratio of 21.7, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Integra LifeSciences as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. You can view the full Integra LifeSciences Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

null

More from Markets

Canopy Growth Lets Down Eager Pot Investors; PayPal Keeps Dominating -- ICYMI

Canopy Growth Lets Down Eager Pot Investors; PayPal Keeps Dominating -- ICYMI

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers